Lyrinel XL use in children

The licence for Lyrinel XL (oxybutynin prolonged release) has been extended to include use in children over six years. Previously, use in children under 18 years was not recommended.

The recommended starting dose for children over six years is 5mg once daily, increasing by 5mg increments up to a maximum of 15mg once daily. The safety and efficacy of Lyrinel XL has not been established in patients under six years.

Further information: Janssen-Cilag Ltd 01494 567444

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

MST Continus granules to be discontinued

MST Continus granules to be discontinued

All strengths of MST Continus (morphine) prolonged-release...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

'Innovative' heart failure treatment recommended by NICE

'Innovative' heart failure treatment recommended by NICE

Dapagliflozin (Forxiga), the first SGLT2 inhibitor...